Sort
8,912 grants matching “sars cov 2”
Leveraging Social Networks to Increase COVID-19 Testing Uptake: A Comparison of Credible Messenger and Chain Referral Recruitment Approaches
$210,209Katherine S Elkington · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · UG1 · FY2022 · DA
Phase 1 Clinical Trial of CMS121, a Novel Therapeutic Candidate for Alzheimer's Disease
$210,130William C Raschke · Virogenics, Inc. · R01 · FY2022 · AG
Project 3: SARS CoV-2 Lung Organoid Interactions in Replication and Pathogenesis
$210,097Ralph S Baric · Stanford University · U19 · FY2022 · AI
Effect of Ubiquitin D variants upon APOL1-mediated kidney injury
$210,000Michael J Ross · Albert Einstein College Of Medicine · R21 · FY2025 · DK
Molecular analysis of glutamatergic neurons derived from iPSCs containing PPM1D truncating mutations found in Jansen de Vries Syndrome
$210,000Herbert M Lachman · Albert Einstein College Of Medicine · R21 · FY2023 · MH
Correlating neutrophil function and plasma cytokine profiles with progression of ME/CFS and Long-Covid/PASC
$210,000Felix Ellett · Massachusetts General Hospital · R21 · FY2024 · NS
Evaluating Clinical and Immunological Consequences of SARS-CoV-2 Vaccination in Rheumatic Disease
$209,880Robyn Therese Domsic · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AR
Host Substrate Profiling of SARS-CoV-2 Virus Protease
$209,821Ronak R Tilvawala · University Of Kansas Lawrence · P20 · FY2021 · GM
Sequencing Core
$209,628Gregory Seumois · La Jolla Institute For Immunology · U19 · FY2024 · AI
Imaging Mass Spectrometry for metabolome mapping
$209,619Mirjana Maletic-Savatic · Baylor College Of Medicine · R01 · FY2020 · GM
Host Substrate Profiling of SARS-CoV-2 Virus Protease
$209,462Ronak R Tilvawala · University Of Kansas Lawrence · P20 · FY2022 · GM
Intracellular Membrane Attack Complexes and COVID-19 Immune Hyperactivation
$209,375Daniel Jane-Wit · Yale University · R21 · FY2024 · AI
Interplay between canonical and non-canonical interferons in defense against respiratory viruses
$209,375Ellen Flescher Foxman · Yale University · R21 · FY2025 · AI
SARS-CoV-2 infection and MHC class I function in bats
$209,375Peter Cresswell · Yale University · R21 · FY2023 · AI
Reversing aging-induced lymphatic dysfunction to improve immune function
$209,320Timothy P Padera · Massachusetts General Hospital · R21 · FY2023 · AG
Investigation of Dpp9 in COVID19
$209,162Richard A Flavell · Yale University · R21 · FY2024 · AI
Background Oriented Schlieren (BOS) Visualization for Evaluation of Risk in Aerosol-Generating Procedures
$208,902Bryan Schmidt · Case Western Reserve University · R21 · FY2023 · EB
Mapping Immune Responses to CMV in Renal Transplant Recipients - Mechanistic Assays Core (UCSF)
$208,861Elaine F Reed · University Of California Los Angeles · U19 · FY2020 · AI
Chimeric ACE2 peptide ligand for diagnostic assays of SARS-CoV-2
$208,788Alexander Wlodawer · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
COVID-19 imprints airway basal cells to impair epithelium regeneration
$208,750Xingbin Ai · Massachusetts General Hospital · R21 · FY2024 · AI
Glial activation and metabolite contributions to 'brain fog' post-acute sequelae of COVID-19 (PASC)
$208,750Michael B Vanelzakker · Massachusetts General Hospital · R21 · FY2024 · NS
Microbiota-Mediated Bidirectional Interactions Between Alcohol Misuse and Post-COVID-19 Syndrome
$208,746Ali Keshavarzian · Rush University Medical Center · R01 · FY2022 · AA
Project II: Adaptive Immunity and AT1-AA in Mediating the PE Phenotype and Long-term Effects on Offspring
$208,560Babbette Babbette Lamarca · University Of Mississippi Med Ctr · U54 · FY2025 · HL
Antibody Core
$208,535Ali Hassan Ellebedy · Icahn School Of Medicine At Mount Sinai · P01 · FY2023 · AI
SARS-CoV-2: Pathogenesis and Countermeasure Development
$208,265Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI